Remove 2013 Remove Diagnose Remove Disease
article thumbnail

Benign breast disease found on percutaneous biopsy ups cancer risk

AuntMinnie

Benign breast disease diagnosed through percutaneous biopsy increases the overall risk of developing breast cancer, according to research published December 13 in JAMA Surgery. Benign breast disease makes up about 75% of breast biopsy diagnoses. The study included data from 4,819 women with a median age of 51.

Disease 306
article thumbnail

AI model predicts 5-year breast cancer risk from mammogram data

AuntMinnie

While attending regular screening mammogram appointments is important in lowering the risk of dying from breast cancer, pinpointing which women are at higher risk of developing the disease can be tricky. They cautioned that with this in mind, the algorithm could be relied on too heavily by radiologists and lead to incorrect diagnoses.

Mammogram 290
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.

article thumbnail

CT reveals autoimmune features linked to indeterminate pneumonia

AuntMinnie

The study included 210 patients with UIP confirmed by lung biopsy between January 2013 and February 2020. The team diagnosed patients with IPAF according to current guidelines; assessed CT patterns that could indicate CTD (anterior upper lobe, straightedge, and exuberant honeycombing signs); and evaluated patients' overall survival.

Disease 130
article thumbnail

Y-90 TARE improves survival in patients with large liver tumors

AuntMinnie

Despite efforts to improve surveillance for hepatocellular carcinoma (HCC), more than half of patients are diagnosed at an advanced stage with large tumors that are difficult to remove surgically without permanently damaging the liver, the authors explained. The mean tumor size of patients who underwent TAE (n = 44) was 10.4

article thumbnail

American Cancer Society Releases Updated Lung Cancer Screening Guidelines

Imaging Technology

The guideline, last updated in 2013, is published in the ACS flagship journal, CA: A Cancer Journal for Clinicians. In 2023, ACS researchers estimate 238,340 new cases of lung cancer (117,550 in men and 120,790 in women) will be diagnosed with about 127,070 deaths from the disease (67,160 in men and 59,910 in women).

article thumbnail

Philips Strengthens its Leadership in Digital Pathology as its Philips IntelliSite Pathology Solution Receives 510(k) Clearance

Imaging Technology

mtaschetta-millane Fri, 07/12/2024 - 11:00 July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort more than in any other area of medicine. This seamless integration helps pathologists deliver accurate diagnoses, ultimately improving patient outcomes.

IT 111